In 2014 Bryce Olson, an Intel executive, was diagnosed with stage IV cancer. He should not be alive today based on his prognosis. But he fought cancer differently. He used DNA sequencing data to break into a perfect-fit drug trial, engineering an ‘exceptional response’ and shutting down his cancer for 2 years. In 2017 his cancer came back. As a pioneer in an era of ‘Precision Medicine 2.0’, Bryce works side by side with the scientific, medical, and technology industry to keep him alive.

[Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.]